Table 1.

Anthropometric and Biochemical Parameters of All Studied Animal Groups.

	Group I negative control N = 10	Group II nontreated NAFLD group model N = 11	Group III positive control group N = 10	Group IV NAFLD + vitamin D supplement N = 14	ANOVA P value
Weight (gm)	194.80 ± 1.81	343.55 ± 5.80a	199.70 ± 2.68b	337.71 ± 3.72a,c	<0.001
Height (cm)	21.26 ± 0.45	21.49 ± 0.32	21.23 ± 0.26	21.26 ± 0.34	0.94
BMI (gm/cm2)	0.43 ± 0.06	0.74 ± 0.07c	0.44 ± 0.03a,b	0.72 ± 0.07a,b	<0.001
Hepatic index	0.05 ± 0.001	0.04 ± 0.001a	0.05 ± 0.001b	0.04 ± 0.001a,c	<0.001
Insulin (μu/L)	25.54 ± 0.93	35.72 ± 0.92a	24.56 ± 1.69b	36.56 ± 1.10a,c	<0.001
Glucose (mmol/L)	5.28 ± 0.35	7.88 ± 0.28a	4.69 ± 0.26b	7.72 ± 0.22a,c	<0.001
HOMA-IR	0.33 ± 0.03	0.69 ± 0.03a	0.28 ± 0.03b	0.69 ± 0.03a,c	<0.001
T Chol. (mmol/L)	2.73 ± 0.23	4.71 ± 0.30a	2.82 ± 0.23b	4.59 ± 0.38a,c	<0.001
TG (mmol/L)	1.04 ± 0.08	1.33 ± 0.21a	1.00 ± 0.09b	1.23 ± 0.23a,c	0.001
LDL-C (mmol/L)	1.19 ± 0.17	2.34 ± 0.74a	1.00 ± 0.09b	1.72 ± 0.44a,c	0.001
HDL-C (mmol/L)	1.07 ± 0.10	1.53 ± 0.30a	1.01 ± 0.09b	1.89 ± 0.77a,c	<0.001
Albumin (g/dl)	3.51 ± 0.02	3.41 ± 0.04	3.46 ± 0.02	3.48 ± 0.02	0.16
AST (U/L)	44.75 ± 1.03	57.07 ± 0.82a	45.62 ± 0.73b	56.66 ± 1.18a,c	<0.001
ALT (U/L)	35.57 ± 0.76	46.34 ± 0.59a	35.41 ± 0.56b	45.57 ± 0.70a,c	<0.001
ALP (U/L)	67.64 ± 1.10	66.58 ± 1.79	70.45 ± 1.51	64.40 ± 1.66	0.15
GGT (U/L)	8.97 ± 0.13	13.55 ± 0.30a	9.25 ± 0.12b	13.00 ± 0.34a,c	<0.001
25 OHD3 (nmol/l)	13.24 ± 0.23	7.16 ± 0.37a	14.36 ± 0.36b	10.04 ± 0.26a,b,c	<0.001
SMP-30 (pg/ml)	117.20 ± 0.87	83.21 ± 0.81a	116.70 ± 1.19b	84.18 ± 0.76a,c	<0.001

Data are presented as mean ± standard deviation.

Statistical analysis was carried out using one-way analysis of variance (ANOVA) followed by Tukey's post-hoc analysis.

^aSignificantly different from N.C value at P < 0.05.

^bSignificantly different from NAFLD value at P < 0.05.

^cSignificantly different from N.C + Vit D value at P < 0.05.